About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Value of an Intervention to Enhance Adherence in Glaucoma Patients

NCT00756184·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Aristotle University Of Thessaloniki

With

Alcon Research

Age

21–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Newly diagnosed patients with glaucoma
Suboptimally controlled patients with glaucoma
Untreated baseline IOP greater than 21 mm Hg but less than 32 mm Hg
Patients who have not responded satisfactorily to PGA therapy
Patients who are about to have adjunctive therapy administered
Patients who consent to participate in this trial

You may not be if

Glaucoma patients with high pressure
Advanced glaucoma
Patients with side effects to PGA therapy
Unwilling to participate

The record

StatusCompleted

PhasePhase 4

Taking part107

StartedSep 2007

UpdatedSep 28, 2011

Conditions

Clareo Health | Value of an Intervention to Enhance Adherence in Glaucoma Patients